Grace Therapeutics
$3.37
24H
Market Cap
Volume
Supply
Price Chart
About Grace Therapeutics - ACST
Acasti Pharma Inc. is a biopharmaceutical company that historically focused on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. Their flagship drug candidate was CaPre, intended for the treatment of hypertriglyceridemia, which is a condition characterized by high levels of triglycerides in the bloodstream.
What are Grace Therapeutics's core values and mission statement?
Acasti Pharma Inc. is focused on developing and commercializing innovative human therapeutics, and their core mission is to harness the unique properties of omega-3 fatty acids to create drugs that address significant unmet medical needs. Their core values include a commitment to scientific excellence, integrity, and collaboration to advance the health and well-being of patients.
Who founded Grace Therapeutics and when?
Acasti Pharma Inc. was founded in 2008 by the parent company Neptune Wellness Solutions.
Who leads Grace Therapeutics?
As of the last update I have, Jan D'Alvise was serving as the President and Chief Executive Officer of Acasti Pharma Inc. Leadership details can change, so for the most recent information, it is best to consult the company's official website or official press releases.
Where is Grace Therapeutics located, and what is its base country?
Acasti Pharma Inc. is a biopharmaceutical company headquartered in Laval, Quebec, Canada.
On which exchanges is Grace Therapeutics traded?
Acasti Pharma Inc. has been listed on the NASDAQ Capital Market under the ticker symbol ACST and on the TSX Venture Exchange in Canada.
Historical data
Grace Therapeutics (ACST) Price Live Data
The live price of Grace Therapeutics (ACST) is $3.37, with a trading volume of 27,682 in the last 24 hours. Wrapstocks updates the ACST price in real-time. Grace Therapeutics is up 4.01% in the last 24 hours. The company has a live market cap of $34,171,460.00 and a supply of 10,139,899 ACST stocks.
Grace Therapeutics (ACST) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 5 hours and 7 minutes.
